|
|
|
Medicines/Products by Categories |
|
|
|
 |
|
Today we command the Research and Development spawning facilities offered by our State of Art drug formulations, chemical research and analytical development center; equipped with the latest equipments needed for combinational synthesis, ultramodern HPLC & GC systems etc.
|
OBJECTIVES AND ACTIVITIES
- Development of NDDS
- Development of non infringing process
- Development of different Nitazoxanide dosage forms
- New process development for cost effectiveness
- Trouble shooting in plant
- Performance batches
- NCMR handling
- Bioequivalence and bioavailability as per DCI and International guidelines
- Drug regulatory affair and documentation: Dossiers for ANDA’s of different countries, NDA’ s filing in India, patents filing after a thorough scrutiny by attorneys, documentation for getting USFDA, documentation for R & D products, documentation for commercial samples, documentation for bioequivalence samples
- Contract research: from conceptualization till the final dossier of the product
|
|
| Global Launch Status (with regard to the originator) |
| Product |
Status |
| Clarithromycin dispersible tablets |
First |
| Fexofenadine dispersible tablets/ mouth dissolving NDDS |
First |
| Roxithromycin taste masked granules |
First |
| Roxithromycin dispersible tablets |
First |
| Clarithromycin taste masked granules |
Second |
| Clarithromycin sustained release tablets |
Second |
| Nitazoxanide dispersible tablets/ dry syrup |
Second |
|
|
|
|